NASDAQ:CGIX
Delisted

Cancer Genetics Stock News

etoro logo Buy CGIX
*Your capital is at risk
$1.08
+0 (+0%)
At Close: May 27, 2022

100 Biggest Movers From Yesterday

09:30am, Friday, 07'th Feb 2020
Gainers Schrodinger, Inc. (NASDAQ: SDGR) shares jumped 68.5% to close at $28.64 on Thursday after the company priced its IPO at $17 per share. Yield10 Bioscience, Inc. (NASDAQ:...

78 Biggest Movers From Yesterday

12:00am, Tuesday, 24'th Dec 2019

74 Biggest Movers From Friday

12:00am, Monday, 09'th Dec 2019

75 Biggest Movers From Yesterday

12:00am, Tuesday, 03'rd Dec 2019

50 Biggest Movers From Friday

12:00am, Monday, 25'th Nov 2019

66 Biggest Movers From Yesterday

12:00am, Friday, 22'nd Nov 2019
RUTHERFORD, N.J., Nov. 20, 2019 -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced.
Options traders blast Pinduoduo (PDD) and AT&T (T) stocks, while Cancer Genetics scales the Nasdaq
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE